Otolaryngology

(Anne Rayner/Vanderbilt) Nashville Business Journal recently released its 2021 “40 under 40” list of honorees, featuring six Vanderbilt alumni and two faculty members: Maya Bugg, EdD’18, president and CEO, Tennessee Charter School Center Christiane Buggs, MEd’14, board chair, The Metropolitan Nashville Board of Public Education and founding board member… Read More

Jessica Wilson struggled for a year with the continuous positive airway pressure (CPAP) mask that she used to treat her obstructive sleep apnea (OSA). Despite her best intentions, wearing the mask that delivers oxygen and prevents airway obstruction didn’t work for her. Read More

A novel immunotherapy combination induced remarkable regression of tumors in a mouse model of head and neck cancer. Read More

An interdisciplinary team at Vanderbilt that developed an innovative method of programming cochlear implants to help people hear better recently presented at Deerfield Residence, the U.S. Ambassador to Ireland’s official residence in Dublin. Read More

Aron Parekh, Ph.D., assistant professor of Otolaryngology, has received a four-year, $790,000 Research Scholar Grant from the American Cancer Society to further his research into the mechanical and biological properties of cancer cells and the methods by which they leave the initial tumor and spread or metastasize to other parts of the body. Read More

James Netterville, M.D., professor of Otolaryngology and director of the Head and Neck Surgical Oncology Service, has been elected president of the American Academy of Otolaryngology – Head and Neck Surgery (AAO-HNS) and its foundation for the 2012-13 term. He assumed his position in September during the annual meeting in Washington, D.C. Read More

Measuring levels of an enzyme in head and neck tumors may indicate how the tumor will respond to radiation therapy. Read More

A simple procedure can correct ‘tongue-tie,’ a commonly missed condition that could prevent newborns from breastfeeding properly. Read More

A gene signature may be useful in predicting outcomes for patients with rhabdomysarcoma, a form of cancer most commonly diagnosed in children. Read More